Prediction of Response to Trimodality Therapy Using CT-Derived Radiomic Features in Stage III Non-Small Cell Lung Cancer (NSCLC)

被引：0

作者：

Jain, P. ^{[1
]}

Ahmad, U. ^{[2
]}

Murthy, S. ^{[2
]}

Stephans, K. ^{[3
]}

Khorrami, M. ^{[4
]}

Madabhushi, A. ^{[4
]}

Velcheti, V. ^{[1
]}

机构：

[1] Cleveland Clin, Pepper Pike, OH USA

[2] Cleveland Clin, Thorac & Cardiovasc Surg, Cleveland, OH 44106 USA

[3] Cleveland Clin, Radiat Oncol, Cleveland, OH 44106 USA

[4] Case Western Reserve Univ, Biomed Engn, Cleveland, OH 44106 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期

关键词：

radiomics; non-small cell lung cancer; chemoradiation;

D O I：

10.1016/j.jtho.2017.09.617

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA 17.11

引用

页码：S1875 / S1875

页数：1

共 50 条

[11] CT-derived radiomic analysis for predicting the survival rate of patients with non-small cell lung cancer receiving radiotherapy
Zhang, Nannan
Zhang, Xinxin
Li, Junheng
Ren, Jie
Li, Luyang
Dong, Wenlei
Liu, Yixin
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2023, 107
[12] Trimodality therapy in the treatment of stage IIIA non-small cell lung cancer (NSCLC): Analysis of the National Cancer Database.
Behera, Madhusmita
Steuer, Conor Ernst
Fernandez, Felix
Liu, Yuan
Fu, Chao
Gillespie, Theresa Wicklin
Higgins, Kristin Ann
Saba, Nabil F.
Pillai, Rathi Narayana
Force, Seth
Pakkala, Suchita
Shin, Dong Moon
Owonikoko, Taofeek Kunle
Belani, Chandra Prakash
Curran, Walter J.
Khuri, Fadlo Raja
Ramalingam, Suresh S.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[13] Radiomic Features on Baseline CT Are Predictive of Recurrence in Early Stage Non-Small Cell Lung Cancer Patients
Vaidya, P.
Patil, P.
Choi, H.
Velcheti, V.
Madabhushi, A.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2393 - S2393
[14] Uniqueness of radiomic features in non-small cell lung cancer
Ge, Gary
Zhang, Jie
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2022, 23 (12):
[15] RADIATION DOSE RESPONSE AND CLINICAL OUTCOMES WITH TRIMODALITY THERAPY FOR STAGE IIIA NON-SMALL CELL LUNG CANCER
Merrell, Kenneth
Seder, Christopher
Mou, Benjamin
Wilson, Zachary
Hallemeier, Christopher
Olivier, Kenneth
Wigle, Dennis
Garces, Yolanda
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S156 - S157
[16] Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features
Khorrami, Mohammadhadi
Jain, Prantesh
Bera, Kaustav
Alilou, Mehdi
Thawani, Rajat
Patil, Pradnya
Ahmad, Usman
Murthy, Sudish
Stephans, Kevin
Fu, Pingfu
Velcheti, Vamsidhar
Madabhushi, Anant
LUNG CANCER, 2019, 135 : 1 - 9
[17] Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB-III non-small cell lung cancer patients using radiomic features
Yang, Nong
Yue, Hai-Lin
Zhang, Bai-Hua
Chen, Juan
Chu, Qian
Wang, Jian-Xin
Yu, Xiao-Ping
Jian, Lian
Bin, Ya-Wen
Liu, Si-Ye
Liu, Jin
Zeng, Liang
Yang, Hai-Yan
Zhou, Chun-Hua
Jiang, Wen-Juan
Liu, Li
Zhang, Yong-Chang
Xiong, Yi
Wang, Zhan
THORACIC CANCER, 2023, 14 (28) : 2869 - 2876
[18] Radiomic phenotype features predict pathological response in non-small cell lung cancer
Coroller, Thibaud P.
Agrawal, Vishesh
Narayan, Vivek
Hou, Ying
Grossmann, Patrick
Lee, Stephanie W.
Mak, Raymond H.
Aerts, Hugo J. W. L.
RADIOTHERAPY AND ONCOLOGY, 2016, 119 (03) : 480 - 486
[19] Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer
de Jong, Evelyn E. C.
van Elmpt, Wouter
Rizzo, Stefania
Colarieti, Anna
Spitaleri, Gianluca
Leijenaar, Ralph T. H.
Jochems, Arthur
Hendriks, Lizza E. L.
Troost, Esther G. C.
Reymen, Bart
Dingemans, Anne-Marie C.
Lambin, Philippe
LUNG CANCER, 2018, 124 : 6 - 11
[20] Proton therapy for stage I non-small cell lung cancer (NSCLC)
Nihei, K
Ogino, T
Ishikura, S
Nishimura, H
Kawashima, M
Arahira, S
Onozawa, M
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S282 - S282

← 1 2 3 4 5 →